Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001209191-23-042101

Director acquired 4,466 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Broder Samuel Director 2023-07-10 Grant or award +4,466 8,932 D
Derivatives
Broder Samuel Director 2023-07-10 Grant or award · Stock Option (Right to Buy) +14,550 14,550 D
Loading xslF345X04/doc4.xml…